Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Anna-Verena Frey"'
Autor:
Julia C. Kuehn, Patrick Metzger, Nicolas Neidert, Uta Matysiak, Linda Gräßel, Ulrike Philipp, Sabine Bleul, Thomas Pauli, Julia Falkenstein, Henriette Bertemes, Stepan Cysar, Maria Elena Hess, Anna Verena Frey, Jesús Duque-Afonso, Elisabeth Schorb, Marcia Machein, Jürgen Beck, Oliver Schnell, Nikolas von Bubnoff, Anna L. Illert, Christoph Peters, Tilman Brummer, Marco Prinz, Cornelius Miething, Heiko Becker, Silke Lassmann, Martin Werner, Melanie Börries, Justus Duyster, Dieter H. Heiland, Roman Sankowski, Florian Scherer
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-11 (2024)
Abstract Despite major advances in molecular profiling and classification of primary brain tumors, personalized treatment remains limited for most patients. Here, we explored the feasibility of individual molecular profiling and the efficacy of bioma
Externí odkaz:
https://doaj.org/article/1dc07143d8964d58a48d87e8eab4e848
Autor:
Stefanie Kreutmair, Dietmar Pfeifer, Miguel Waterhouse, Ferenc Takács, Linda Graessel, Konstanze Döhner, Justus Duyster, Anna Lena Illert, Anna-Verena Frey, Michael Schmitt, Michael Lübbert
Publikováno v:
Cancer Immunology, Immunotherapy. 71:2913-2928
Wilms’ tumor 1 (WT1) protein is highly immunogenic and overexpressed in acute myeloid leukemia (AML), consequently ranked as a promising target for novel immunotherapeutic strategies. Here we report our experience of a phase I/II clinical trial (NC
Autor:
Meike Burger, Sven Diederichs, Markus G. Manz, Dominik von Elverfeldt, Sanaz Taromi, Mirjam Elze, Annette Schmitt-Graeff, Alicia Schumacher, Bernward Passlick, Bernd Kammerer, Xuekai Zhu, Anna Verena Frey, Justus Duyster, Simon Lagies, Alexander Simonis, Elke Firat, Robert Zeiser, Gabriele Niedermann, Petya Apostolova, Marie Follo, Katrin Schmittlutz, Lukas Braun
Publikováno v:
Cancer Letters. 520:385-399
Metastatic small cell lung cancer (SCLC) is not curable. While SCLC is initially sensitive to chemotherapy, remissions are short-lived. The relapse is induced by chemotherapy-selected tumor stem cells, which express the AC133 epitope of the CD133 ste
Publikováno v:
PathoMaps ISBN: 9783662649268
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df3bf9ad754f25935cd214e97ac862a3
https://doi.org/10.1007/978-3-662-64927-5_18
https://doi.org/10.1007/978-3-662-64927-5_18
Autor:
Lisa Kristina Isbell, Cordula Tschuch, Soroush Doostkam, Silvia Waldeck, Geoffroy Andrieux, Khalid Shoumariyeh, Dorothee Lenhard, Hans Eckart Schaefer, Peter Christoph Reinacher, Ingrid Bartsch, Milena Pantic, Janaki Manoja Vinnakota, Vinodh Kakkassery, Elisabeth Schorb, Florian Scherer, Anna Verena Frey, Melanie Boerries, Gerald Illerhaus, Justus Duyster, Julia Schueler, Nikolas von Bubnoff
Aims: How and why lymphoma cells home to the central nervous system and vitreoretinal compartment in primary diffuse large B-cell lymphoma of the central nervous system remain unknown. Our aim was to create an in vivo model to study lymphoma cell tro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68a847c7487053c2c39ec80d091bb8fd
https://publica.fraunhofer.de/handle/publica/442755
https://publica.fraunhofer.de/handle/publica/442755
Publikováno v:
PathoMaps ISBN: 9783662649268
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92191d4ec5efd73ad84360a87c7e9aba
https://doi.org/10.1007/978-3-662-64927-5_19
https://doi.org/10.1007/978-3-662-64927-5_19
Autor:
Thomas Kowalski, Alexander Baraniskin, Ulrich Herrlinger, Michelle Margold, Uwe Schlegel, Sabine Seidel, Anna Verena Frey, Agnieszka Korfel, Roland Schroers, Swetlana Ladigan, Ingo G.H. Schmidt-Wolf
Publikováno v:
Neuro-Oncology
Neuro Oncol
Neuro Oncol
Background In patients with presumed primary CNS lymphoma (PCNSL), a systemic manifestation is found only in a small minority. Although bone marrow biopsy (BMB) is recommended for staging, its diagnostic value is unclear. Methods A retrospective anal
Autor:
Anna Lena Illert, Nikolas von Bubnoff, Rouven Hoefflin, Michel Eisenblaetter, Philipp Poxleitner, Patrick Metzger, Nico Buettner, Florian Scherer, Anna-Lena Geißler, Alexander Keller, Melanie Boerries, Alexandra Kutilina, Ralph Fritsch, Christine Dierks, Jesus Duque-Afonso, Adriana Lazarou, Isabell Xiang Ge, Justus Duyster, Steffen Heeg, Frank Meiss, Andreas Tzschach, Anna Verena Frey, Cornelius Miething, Gian Kayser, Simone Hettmer, Martin Werner, Leman Mehmed, Heiko Becker, Justyna Rawluk, Julius Wehrle, Dieter Henrik Heiland, Khalid Shoumariyeh, Markus Grabbert, Tilman Brummer, Juri Ruf, Thalia Erbes, Christoph Peters, Konrad Aumann, Kai Berner, Maria Elena Hess, Meike Reiser, Martin Boeker, Anita Kleiber, Silke Lassmann, Henning Schäfer
Publikováno v:
Cancers
Volume 13
Issue 5
Cancers, Vol 13, Iss 1151, p 1151 (2021)
Volume 13
Issue 5
Cancers, Vol 13, Iss 1151, p 1151 (2021)
Simple Summary Access to molecular cancer treatments outside of clinical trials is limited and the benefit of molecular-guided, individualized patient care in patients with cancer progression after standard treatment is unclear. We here present the f
Publikováno v:
Springer-Lehrbuch ISBN: 9783662574386
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbfa95f7074a2472c255289e64a7b9b5
https://doi.org/10.1007/978-3-662-57439-3_19
https://doi.org/10.1007/978-3-662-57439-3_19
Publikováno v:
Springer-Lehrbuch ISBN: 9783662574386
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97f0fae8bba536b0e31a298898ae04df
https://doi.org/10.1007/978-3-662-57439-3_18
https://doi.org/10.1007/978-3-662-57439-3_18